Gls Pharma Limited, a active public limited company, was established on 01 September 2004 in Seri Lingampally, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239TS2004PLC184306. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.30 Cr and a paid-up capital of ₹1.20 Cr.
Formerly known as Gls Pharma Private Limited, Getwell Life Sciences India Private Limited.. It upholds a compliant status. Employing 116 professional, Its leadership includes Srinivasa Ramachandra Rao Ilapakurthy (Director), Suresh Pathak (Director), Ravikiran Namburi (Additional Director). Past directors included Sanjay Koganti, Surbhi Pathak, Sanjeev Indravadan Dani. It holds ₹2.00 Cr open charges and ₹15.83 Cr settled loans. Its latest AGM occurred on 22 September 2025, with the balance sheet filed on 31 March 2025. It is based at Galaxy, Floors 22-24, Plot No. 1, Survey No. 83/1,, Hyderabad Knowledge City, Raidurg Panmaktha,, Seri Lingampally, Telangana, 500032.
U24239TS2004PLC184306
184306
01 September 2004
₹1.30 Cr
₹1.20 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Gls Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Srinivasa Ramachandra Rao Ilapakurthy | Director | 15 Dec 2023 | Current |
| Suresh Pathak | Director | 01 Sep 2004 | Current |
| Ravikiran Namburi | Additional Director | 20 Sep 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Additional Director | 30 Dec 2020 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2022 | Past |
| Pramod Abcsdd | Director | 26 Aug 2019 | Past |
| Pramod Abcsdd | Additional Director | 12 Aug 2015 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Gls Pharma Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13862.3% increase. The company also saw a substantial improvement in profitability, with a 8628.69% increase in profit. The company's net worth Soared by an impressive increase of 22564.11%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Gls Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹20,000,000.00
₹158,300,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Sep 2022 | Canara Bank | ₹2.00 Cr | Open |
| 30 Aug 2021 | Canara Bank | ₹2.50 Cr | Satisfied |
| 15 Dec 2020 | Syndicate Bank | ₹9.60 M | Satisfied |
| 14 Dec 2020 | Canara Bank | ₹8.00 M | Satisfied |
| 30 Sep 2015 | Syndicate Bank | ₹7.97 Cr | Satisfied |
Explore comprehensive loan charge details -
Gls Pharma has a workforce of 116 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Gls Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gls Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Gls Pharma Limited last Annual general meeting of members was held on 22 Sep 2025 as per latest MCA records. was recorded as a recent event.
Progress on A charge with Canara Bank of Rs. 2.00 Cr registered on 20 Sep 2022 with Charge ID 100616943 was modified on 18 Jun 2025. was documented.
Progress on Gls Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was documented.
The activity A charge registered on 11 Jan 2007 via Charge ID 10033531 with Icici Bank Limited was fully satisfied on 20 Jan 2025. was completed.
The activity Ravikiran Namburi was appointed as a Additional Director was appointed as a Additional Director on 20 Sep 2024 & has been associated with this company since 1 year 2 months . was completed.
The activity Srinivasa Ramachandra Rao Ilapakurthy was appointed as a Director was appointed as a Director on 15 Dec 2023 & has been associated with this company since 1 year 11 months . was completed.
The CIN of Gls Pharma Limited is U24239TS2004PLC184306.
Gls Pharma Limited is headquartered at Galaxy, Floors 22-24, Plot No. 1, Survey No. 83/1,, Hyderabad Knowledge City, Raidurg Panmaktha,, Seri Lingampally, Telangana, 500032.
Gls Pharma Limited was incorporated on 01 September 2004.
The current directors of Gls Pharma Limited are
The primary industry of Gls Pharma Limited is Manufacturing.
Gls Pharma Limited is unlisted.
The authorized capital of Gls Pharma Limited is ₹1.30 Cr, and the paid-up capital is ₹1.20 Cr.
The compliance status of Gls Pharma Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX